Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A monoclonal antibody against leptin.
Mahmoudian J, Jeddi-Tehrani M, Bayat AA, Mahmoudi AR, Vojgani Y, Tavangar B, Hadavi R, Zarei S. Mahmoudian J, et al. Hybridoma (Larchmt). 2012 Oct;31(5):372-7. doi: 10.1089/hyb.2012.0045. Hybridoma (Larchmt). 2012. PMID: 23098305
Opticin, a small leucine-rich proteoglycan, is uniquely expressed and translocated to the nucleus of chronic lymphocytic leukemia cells.
Mikaelsson E, Osterborg A, Tahmasebi Fard Z, Mahmoudi A, Mahmoudian J, Jeddi-Tehrani M, Akhondi M, Shokri F, Bishop PN, Rabbani H, Mellstedt H. Mikaelsson E, et al. Among authors: mahmoudian j. Exp Hematol Oncol. 2013 Aug 28;2(1):23. doi: 10.1186/2162-3619-2-23. Exp Hematol Oncol. 2013. PMID: 24499526 Free PMC article.
Cloning, expression and characterization of a peptibody to deplete myeloid derived suppressor cells in a murine mammary carcinoma model.
Ramezani-Ali Akbari K, Khaki-Bakhtiarvand V, Mahmoudian J, Asgarian-Omran H, Shokri F, Hojjat-Farsangi M, Jeddi-Tehrani M, Shabani M. Ramezani-Ali Akbari K, et al. Among authors: mahmoudian j. Protein Expr Purif. 2022 Dec;200:106153. doi: 10.1016/j.pep.2022.106153. Epub 2022 Aug 19. Protein Expr Purif. 2022. PMID: 35995320
Evaluation of the anti-tumor effects of an anti-Human Epidermal growth factor receptor 2 (HER2) monoclonal antibody in combination with CD11b+/Gr-1+ myeloid cells depletion using a recombinant peptibody in 4 T1-HER2 tumor model.
Ramezani-Aliakbari K, Khaki-Bakhtiarvand V, Mahmoudian J, Asgarian-Omran H, Shokri F, Hojjat-Farsangi M, Jeddi-Tehrani M, Shabani M. Ramezani-Aliakbari K, et al. Among authors: mahmoudian j. Int Immunopharmacol. 2023 Aug;121:110463. doi: 10.1016/j.intimp.2023.110463. Epub 2023 Jun 14. Int Immunopharmacol. 2023. PMID: 37327513
21 results